Inositol
CAS 87-89-8
Inositol (CAS 87-89-8) is a Phase 3 pharmaceutical compound with 4 bioactivity targets and 1,473 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 928532.7854716982 nM | 53 | - |
| - | AC50 | 27701.738235294117 nM | 34 | - |
| - | Potency | 13755.2 nM | 4 | - |
| - | IC50 | 16650.873333333333 nM | 2 | - |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Needle fatigue | 10 | 62.531 | 10077304 |
| Gait spastic | 10 | 59.416 | 10017585 |
| Relapsing-remitting multiple sclerosis | 10 | 57.764 | 10063399 |
| Exposure during pregnancy | 25 | 53.884 | 10073513 |
| Normal newborn | 12 | 53.358 | 10029769 |
| Hypertonic bladder | 11 | 52.056 | 10020853 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| INOSITOL | 5833 | SU | MTHSPL |
| inositol | 5833 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Inositol used for in pharmaceutical contexts?
Inositol (CAS 87-89-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Inositol?
Inositol has 1,473 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Needle fatigue, Gait spastic, Relapsing-remitting multiple sclerosis, Exposure during pregnancy, Normal newborn. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Inositol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Inositol with EU status "permitted".
What clinical phase is Inositol in?
Inositol is rendered with ChEMBL max phase 3.